Stay up to date with the treatment of recurrent/metastatic cervical cancer according to current guidelines and learn more about the key safety considerations for immunotherapy and targeted treatments.
Watch now with leading experts: touchoncologyi...
This activity is funded by an independent medical education grant from Merck and Co., Inc and Seagen Inc. This activity is jointly provided by USF Health and touchIME.
7 окт 2024